A Novel Hypoxic-Angiogenesis-Immune-Related Gene Model for Prognostic and Therapeutic Effect Prediction in Hepatocellular Carcinoma Patients

Figure 3

8-gene characteristic model prognostic analyzed in ICGC cohort. (a) The distribution and median value of the risk score in the ICGC cohort. (b) The distributions of OS condition, OS, and risk score in the ICGC queue. (e) Kaplan-Meier curves of OS in the high- and low-risk TCGA cohorts for HCC patients in the ICGC cohort. (c) PC plot of the ICGC cohort. (d) t-SNE analysis of the ICGC cohort. (f) The area under the curve of time-dependent ROC curves validated the prognostic manifestation of the risk score in the ICGC queue.

(a)

(b)

(c)

(d)

(e)

(f)